Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Purine nucleoside phosphorylase gene therapy for human malignancy

Purine nucleoside phosphorylase gene therapy for human malignancy

US Patent 6017896 · Granted Jan 25, 2000

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cystic fibrosis transmembrane conductance regulator (CFTR) modulators, pharmaceu2025
Enhanced therapeutic usage of a purine nucleoside phosphorylase or nuceloside hy2025
Enhanced therapeutic usage of a purine nucleoside phosphorylase or nuceloside hy2025
Methods, systems, arrangements and computer-accessible medium for providing micr2021
Methods, systems, arrangements and computer-accessible medium for providing micr2019
Enhanced therapeutic usage of a purine nucleoside phosphorylase or nucleoside hy2018
Enhanced therapeutic usage of a purine nucleoside phosphorylase or nucleoside hy2018
Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs2014
Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs2014
Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof2009
Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof2009
Compounds promoting delivery of genes2009